KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,993,000 | +88.0% | 83,385 | +8.4% | 0.02% | +88.9% |
| Q2 2017 | $7,977,000 | +32.1% | 76,950 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $6,040,000 | +106.4% | 76,950 | +17.9% | 0.01% | +60.0% |
| Q4 2016 | $2,926,000 | -17.6% | 65,250 | +2.7% | 0.01% | -16.7% |
| Q3 2016 | $3,550,000 | +11.0% | 63,550 | -0.6% | 0.01% | +20.0% |
| Q2 2016 | $3,198,000 | +15.2% | 63,950 | +2.1% | 0.01% | 0.0% |
| Q1 2016 | $2,776,000 | -5.9% | 62,650 | +30.9% | 0.01% | -28.6% |
| Q4 2015 | $2,949,000 | +41.8% | 47,850 | +28.1% | 0.01% | +40.0% |
| Q3 2015 | $2,080,000 | +6.8% | 37,350 | +16.9% | 0.01% | 0.0% |
| Q2 2015 | $1,948,000 | +1.6% | 31,950 | -3.9% | 0.01% | 0.0% |
| Q1 2015 | $1,918,000 | +7.5% | 33,250 | +7.4% | 0.01% | -28.6% |
| Q4 2014 | $1,785,000 | – | 30,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |